This finding has been documented in about a half of breast cancers and a quarter of pancreatic adenocarcinomas, suggesting a potential autocrine loop of the KGF/KGFR axis in these tumor cells [21], [43], [44]. This evidence concerns the gene FGFR2 and neoplasm.